LCM
EW icon

LCM Capital Management’s Edwards Lifesciences EW Stock Holding History

LCM Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Buy
2,818
+89
+3% +$7.46K 0.11% 94
2026
Q1 		$219K Buy
2,729
+50
+2% +$4.12K 0.11% 99
2025
Q4 		$228K Sell
2,679
-110
-4% -$9.03K 0.11% 92
2025
Q3 		$217K Buy
2,789
+6
+0.2% +$469 0.1% 97
2025
Q2 		$218K Buy
2,783
+23
+0.8% +$1.72K 0.11% 97
2025
Q1 		$200K Buy
+2,760
New +$198K 0.12% 97
2024
Q3 		– Sell
-2,541
Closed -$235K – 99
2024
Q2 		$235K Buy
2,541
+123
+5% +$10.9K 0.15% 79
2024
Q1 		$231K Buy
+2,418
New +$203K 0.15% 81

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

LCM Capital Management's EW Position: Q2 2026 in Review

LCM Capital Management increased its Edwards Lifesciences (EW) stake by 3.3% in Q2 2026, buying an estimated $7.46K and bringing the position to 2,818 shares worth $255K. The position accounts for 0.11% of the portfolio, ranked #94.

LCM Capital Management first reported a position in EW in Q1 2024 and has held it in 8 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • LCM Capital Management held 2,818 shares of Edwards Lifesciences worth $255K as of Q2 2026.
  • LCM Capital Management bought 89 Edwards Lifesciences shares in Q2 2026, an estimated $7.46K.
  • Edwards Lifesciences made up 0.11% of LCM Capital Management's portfolio in Q2 2026, its #94 holding.
  • LCM Capital Management first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 8 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on LCM Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.